Estradiol Patch and Caffeine Interaction: What You Actually Need to Know

Does the estradiol patch interact with caffeine?

Nothing in the Climara or Vivelle-Dot drug interactions sections names caffeine. They describe a different set: estrogens are partly metabolized by CYP3A4, so CYP3A4 inducers such as St. John's wort, phenobarbital, carbamazepine and rifampin may lower estrogen levels, and inhibitors such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice may raise them [1][2].

The more relevant direction runs the other way. Caffeine is cleared mainly by CYP1A2, which catalyses its 3-N-demethylation to paraxanthine, the main pathway in humans, and the FDA lists caffeine as a clinical index substrate for CYP1A2 [6][10]. In the oral estradiol study, estrogen lowered the paraxanthine-to-caffeine ratio, suggesting that it may inhibit CYP1A2; the study did not directly measure caffeine clearance [3].

What the estrogen studies actually measured

The most direct study used oral estradiol tablets. Twelve healthy postmenopausal women took estradiol (Estrace), started at 0.5 mg a day and titrated to a steady-state plasma level of 50 to 150 pg/mL, for 8 weeks. Their caffeine metabolic ratio (paraxanthine to caffeine, a CYP1A2 marker) fell by a mean of 29.2, with a standard deviation of 25.0, p = 0.0019, compared with the same women before treatment. The authors concluded that exogenous estrogen in older women may inhibit CYP1A2-mediated caffeine metabolism [3].

Two studies of combined oral contraceptives, which contain a different estrogen (ethinyl estradiol), point the same way. In Abernethy and Todd 1985, women who had taken low-dose estrogen pills for more than 3 months were compared with 9 matched controls after a 162 mg caffeine dose. Caffeine half-life was 7.88 hours versus 5.37 hours, and clearance was 1.05 versus 1.75 mL/min/kg, roughly 40% lower. Volume of distribution was unchanged [4]. In Patwardhan 1980, 9 pill users and 9 non-users given 250 mg of caffeine had half-lives of 10.7 and 6.2 hours respectively, with clearances of 0.79 and 1.3 mL/min/kg [5].

Does the transdermal route change the size of the effect?

The Climara label says the systemic availability of estradiol after transdermal use is about 20 times higher than after oral use because there is no first-pass metabolism [1]. The studies above used oral estradiol or oral contraceptive pills, not patches, so they do not show what a patch does to caffeine clearance [3][4][5].

How long caffeine lasts

In healthy adults, reported mean half-lives cluster roughly between 3.4 and 6.2 hours, with wide individual spread: 3.4 hours (range 2 to 5) in one sample of 25 men and non-pregnant women [7], 6.0 hours in non-smokers [8], and 5.37 and 6.2 hours in the control groups of the two contraceptive studies [4][5]. Smokers clear caffeine faster, with a mean of 3.5 hours in one comparison [8].

A longer half-life means caffeine stays in the body longer. The estradiol study in postmenopausal women measured a metabolite ratio rather than half-life, so it did not put a number of hours on any change [3]. The half-life figures above for pill users come from women taking ethinyl estradiol pills [4][5].

Side effects listed in the Climara label

The Climara label's adverse reaction table pools several trials; the 72-woman placebo group comes from a hot-flush trial. Breast pain was reported by 5% of women at 0.025 mg per day, 8% at 0.05 mg per day and 29% at 0.1 mg per day, against 4% on placebo. Headache was reported by 5%, 18% and 13% versus 10%; nausea by 1%, 5% and 6% versus 3%; and edema by 0.5%, 13% and 10% versus 6% [1].

The postmarketing list, which has no frequencies because reports are voluntary, includes palpitations, insomnia, anxiety, nervousness, breast pain and breast tenderness [1]. The label does not attribute any of these to caffeine [1].

How much caffeine is generally considered moderate?

The FDA cites 400 mg a day, about two to three 12-fluid-ounce cups of coffee, as an amount not generally associated with negative effects in healthy adults. It notes wide variation in both sensitivity to caffeine and how quickly people eliminate it, and that some conditions and medications raise sensitivity [9].

Caffeine content varies widely. Per 12 fluid ounces, the FDA lists 23 to 83 mg for caffeinated soft drinks, 37 mg for green tea, 71 mg for black tea, 113 to 247 mg for regular brewed coffee and 41 to 246 mg for energy drinks, with energy drinks generally 54 to 328 mg per 16 fluid ounces. Decaf coffee typically contains 2 to 15 mg per 8-ounce cup [9].

The bottom line

Caffeine does not appear in the drug interactions sections of the Climara or Vivelle-Dot labels [1][2]. Oral estradiol lowered a marker of caffeine metabolism in 12 postmenopausal women [3], and estrogen-containing contraceptive pills slowed measured caffeine clearance [4][5]. The effect of an estradiol patch on caffeine has not been measured in these studies.